from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2352c/PPE38

LFCtreatmentdescriptionclass of inhibitor

1.006

Amikacinug/mL Amikacintranslation

1.064

Cap5-10ug/mL Capreomycintranslation

1.307

Rox10-50 ug/mL Roxithromycintranslation

0.148

SM2-5 ug/mL Streptomycintranslation

1.457

Tet5-10 ug/mL Tetracyclinetranslation

0.148

Rif0.2-5ug/mL Rifampicintranscription

0.477

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.683

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.506

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.373

CPZ10-50 ug/mL Chlorpromazinerespiration

0.098

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.003

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.477

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.203

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.732

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.316

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.121

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.143

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.876

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.250

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.539

KCN5-20 ug/mL Potassium cyaniderespiration

0.183

NaN30.2-2 mM Sodium aziderespiration

0.102

Nigericin50 uM Nigericinrespiration

-0.455

TRC10-150 ug/mL Triclosanrespiration

-0.785

TRZ10-25 ug/mL Thioridazinerespiration

-0.330

Valinomycin0.5-10 uM Valinomycinrespiration

-0.438

ZnSO42 mM ZnSO4respiration

0.173

menadione6-10 ug/mL Menadionerespiration

0.248

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.039

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.571

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.451

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.327

NRP_1Non-replicating persistence stage 1dosRassociated

-0.274

Amp0.2mg/mL AmpicillincellWall

0.030

Cephalexin20-100 ug/mL CephalexincellWall

-0.101

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.346

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.304

EMB10-20 ug/mL EthambutolcellWall

-0.385

Eta12-40 ug/mL EthionamidecellWall

-0.476

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.037

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.177

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.124

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.311

BZA0.12 mg/mL BenzamidearomaticAmides

0.154

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.285

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.497

H2O24 mM hydrogen peroxideDNAdamaging

0.016

Levo10 ug/mL LevofloxacinDNAdamaging

-0.159

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.529

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.312

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.789

UVUV-irradiationDNAdamaging

-0.224

ARP41-4 ug/mL Antitubercular compound ARP4?

0.309

Antimycin12.5-50 ug/mL Antimycin A?

0.649

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.232

PA_110-50 ug/mL Antitubercular compound PA-1?

0.407

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.779

PA8240.2-2 ug/mL PA-824?

-0.139

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.243

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.774

Verapamil50 uM Verapamil?

0.023

mercaptoethanol2 mM 2-Mercaptoethanol?

0.257

methoxatin10-20 ug/mL Methoxatin?